标普和纳斯达克内在价值 联系我们

Addex Therapeutics Ltd ADDXF OTC

Other OTC • Healthcare • Biotechnology • CH • USD

SharesGrow Score
44/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Addex Therapeutics Ltd (ADDXF) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 41/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
~
护城河
50/100
→ Income
~
成长
58/100
→ Income
收入
10/100
→ Income

估值概览 — ADDXF

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率11.43
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.15
每股账面价值$0.00
每股营收$0.09
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $-0.81 $4.43M $-43.88M -989.7%
2014 $-0.55 $5.24M $-36.5M -696%
2015 $-0.59 $7.04M $-47.41M -673.8%
2016 $0.34 $5.92M $33.57M 566.8%
2017 $-0.17 $3.46M $-19.98M -577.7%
2018 $-0.36 $4.99M $-45.99M -922%
2019 $-0.08 $3.52M $-11.71M -333.1%
2020 $-0.14 $1.83M $-20.65M -1130.8%
2021 $-0.26 $4.34M $-43.02M -991%
2022 $-0.15 $14.7M $-26.27M -178.7%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言